1. To understand the concept of drug de-development

  2. To recognize characteristics of drugs for which the labeled dose is too high

  3. To become familiar with strategies incorporating interventional pharmacoeconomics

Session date: 
05/07/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115, HemOnc Conference Room E215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mark J. Ratain, MD